SCHEMBL2993920

SCHEMBL2993920

CC(C(=O)O)[Si](O)(O)O.[SiH4]

nearest known ligand 0.44

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
SLC7A5 Q01650 2/20 0.35
GABRR1 P24046 2/20 0.31
RNPEP Q9H4A4 1/20 0.31
CYP1A2 P05177 1/20 0.31
TDP1 Q9NUW8 2/20 0.30
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL736969 0.97
SCHEMBL22231672 0.94 TP53 (0.42) TP53SLC7A5GABRR1RNPEPCYP1A2
SCHEMBL524402 0.94 TP53 (0.42) TP53SLC7A5GABRR1RNPEPCYP1A2
SCHEMBL451424 0.71
SCHEMBL28798975 0.69 TP53 (0.50) TP53SLC7A5GABRR1RNPEPCYP1A2
SCHEMBL10012564 0.69
SCHEMBL15921098 0.69 TP53 (0.42) TP53SLC7A5GABRR1RNPEPCYP1A2
SCHEMBL30130066 0.68
Lactic Acid SCHEMBL8096437 0.65
Lactic Acid SCHEMBL8096439 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8597959-B2 Methods of use of solid support material for binding biomolecules 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-12-03 US disclosed
US-20100209946-A1 USES OF WATER-DISPERSIBLE SILICA NANOPARTICLES FOR ATTACHING BIOMOLECULES 3M INNOVATIVE PROPERTIES COMPANY 2010-08-19 US disclosed
US-20100184103-A1 METHODS OF USE OF SOLID SUPPORT MATERIAL FOR BINDING BIOMOLECULES 3M INNOVATIVE PROPERTIES COMPANY 2010-07-22 US disclosed
EP-2140264-A1 METHODS OF USE OF SOLID SUPPORT MATERIAL FOR BINDING BIOMOLECULES 3M Innovative Properties Company (US) 2010-01-06 EP disclosed
EP-2137533-A2 USES OF WATER-DISPERSIBLE SILICA NANOPARTICLES FOR ATTACHING BIOMOLECULES 3M Innovative Properties Company (US) 2009-12-30 EP disclosed
WO-2009009188-A2 USES OF WATER-DISPERSIBLE SILICA NANOPARTICLES FOR ATTACHING BIOMOLECULES 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-01-15 WO disclosed
WO-2008131063-A1 METHODS OF USE OF SOLID SUPPORT MATERIAL FOR BINDING BIOMOLECULES 3M INNOVATIVE PROPERTIES COMPANY (US) 2008-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100209946-A1 USES OF WATER-DISPERSIBLE SILICA NANOPARTICLES FOR ATTACHING BIOMOLECULES CD44, SELP, EPCAM TP53 318/4885SLC7A5 1539/4885GABRR1 2678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.